American Journal of Obstetrics & Gynecology
Volume 200, Issue 1 , Pages 98.e1-98.e6 , January 2009

Quantification of cell free fetal DNA in maternal plasma in normal pregnancies and in pregnancies with placental dysfunction

  • Medhat S. Alberry, MRCOG

      Affiliations

    • Department of Fetal Medicine, University of Bristol, St Michael's Hospital, Bristol, UK
    • Department of Obstetrics and Gynecology, Ain-Shams University Maternity Hospital, Cairo, Egypt
    • ,
  • Deborah G. Maddocks, PhD

      Affiliations

    • Centre for Research in Biomedicine, Faculty of Applied Sciences, University of the West of England, Bristol, UK
    • ,
  • Medhat A. Hadi, PhD

      Affiliations

    • Department of Obstetrics and Gynecology, Ain-Shams University Maternity Hospital, Cairo, Egypt
    • ,
  • Helmi Metawi, MD

      Affiliations

    • Department of Obstetrics and Gynecology, Ain-Shams University Maternity Hospital, Cairo, Egypt
    • ,
  • Linda P. Hunt, PhD

      Affiliations

    • Department of Clinical Sciences, Institute of Child Life and Health, University of Bristol at South Bristol, Bristol, UK
    • ,
  • Sherif A. Abdel-Fattah, MD

      Affiliations

    • Department of Fetal Medicine, University of Bristol, St Michael's Hospital, Bristol, UK
    • ,
  • Neil D. Avent, PhD

      Affiliations

    • Centre for Research in Biomedicine, Faculty of Applied Sciences, University of the West of England, Bristol, UK
    • ,
  • Peter W. Soothill, PhD

      Affiliations

    • Department of Obstetrics and Gynecology, University of Bristol, St Michael's Hospital, Bristol, UK

Received 24 January 2008 ,Revised 13 May 2008 ,Accepted 28 July 2008.

References 

  1. Lo YM, Corbetta N, Chamberlain PF, et al. Presence of fetal DNA in maternal plasma and serum. Lancet. 1997;350:485–487
  2. Finning KM, Martin PG, Soothill PW, Avent ND. Prediction of fetal D status from maternal plasma: introduction of a new noninvasive fetal RHD genotyping service. Transfusion. 2002;42:1079–1085
  3. Lo YM. Fetal DNA in maternal plasma: biology and diagnostic applications. Clin Chem. 2000;46:1903–1906
  4. Gonzalez MC, Garcıa HM, Trujillo MJ. Prenatal detection of a cystic fibrosis mutation in fetal DNA from maternal plasma. Prenat Diagn. 2002;22:946–948
  5. Chiu WK, Lau TK, Lo YM. Prenatal exclusion of β-thalassaemia major by examination of maternal plasma. Lancet. 2002;360:998–1000
  6. Lo YM, Leung TN, Tein MS, et al. Quantitative abnormalities of fetal DNA in maternal serum in preeclampsia. Clin Chem. 1999;45:184–188
  7. Caramelli E, Rizzo N, Councu M, et al. Cell-free fetal DNA concentration in plasma of patients with abnormal uterine artery Doppler waveform and intrauterine growth restriction—a pilot study. Prenat Diagn. 2003;23:367–371
  8. Leung TN, Zhang J, Lau TK, Hjelm NM, Lo YM. Maternal plasma fetal DNA as a marker for preterm labour. Lancet. 1998;352:1904–1905
  9. Sekizawa A, Sugito Y, Iwasaki M, et al. Cell-free fetal DNA is increased in plasma of women with hyperemesis gravidarum. Clin Chem. 2001;47:2164–2165
  10. Farina A, LeShane ES, Lambert M. Evaluation of cell-free fetal DNA as a second-trimester maternal serum marker of Down syndrome pregnancy. Clin Chem. 2003;49:239–242
  11. Zimmermann G, Holzgreve W, Avent N, Hahn S. Optimized real-time quantitative PCR measurement of male fetal DNA in maternal plasma. Ann N Y Acad Sci. 2006;1075:347–349
  12. Zimmermann B, El-Sheikhah A, Nicolaides K, Holzgreve W, Hahn S. Optimized real-time quantitative PCR measurement of male fetal DNA in maternal plasma. Clin Chem. 2005;51:1598–1604
  13. Tuffnell DJ, Jankowicz D, Lindow SW, et al. Outcomes of severe pre-eclampsia/ eclampsia in Yorkshire 1999/2003. BJOG. 2005;112:875–880
  14. Douglas KA, Redman CW. Eclampsia in the United Kingdom. BMJ. 1994;309:1395–1400
  15. Chang TC, Robson SC, Spencer JA, Gallivan S. Identification of fetal growth retardation: comparison of Doppler waveform indices and serial ultrasound measurements of abdominal circumference and fetal weight. Obstet Gynecol. 1993;82:230–236
  16. Zhong XY, Laivuori H, Livingston JC. Elevation of both maternal and fetal extracellular circulating deoxyribonucleic acid concentrations in the plasma of pregnant women with preeclampsia. Am J Obstet Gynecol. 2001;184:414–419
  17. Levine RJ, Qian C, Leshane ES, et al. Two-stage elevation of cell-free fetal DNA in maternal sera before onset of preeclampsia. Am J Obstet Gynecol. 2004;190:707–713
  18. Swinkels DW, de Kok JB, Hendriks JC, Wiegerinck E, Zusterzeel PL, Steegers EA. Hemolysis, elevated liver enzymes, and low platelet count (HELLP) syndrome as a complication of preeclampsia in pregnant women increases the amount of cell-free fetal and maternal DNA in maternal plasma and serum. Clin Chem. 2002;48:650–653
  19. Altman D, Carroli G, Duley L, et al. Magpie trial collaboration group Do women with pre-eclampsia, and their babies, benefit from magnesium sulphate? (The Magpie Trial: a randomised placebo-controlled trial). Lancet. 2002;359:1877–1890
  20. Alberry M, Soothill P. Management of fetal growth restriction. Arch Dis Child Fetal Neonatal. 2007;92:62–67
  21. Bobrow CS, Holmes RP, Muttukrishna S, et al. Maternal serum activin A, inhibin A, and follistatin in pregnancies with appropriately grown and small-for-gestational-age fetuses classified by umbilical artery Doppler ultrasound. Am J Obstet Gynecol. 2002;186:283–287
  22. Royston P, Altman DG. Regression using fractional polynomials of continuous covariates: parsimonious parametric modelling (with discussion). Appl Statist. 1994;43:429–467
  23. Royston P, Wright EM. How to construct ‘normal ranges’ for fetal variables. Ultrasound Obstet Gynecol. 1998;11:30–38
  24. Royston P, Wright EM. A method for estimating age-specific reference intervals (‘normal ranges’) based on fractional polynomials and exponential transformation. J Roy Statist Soc. 1998;161:79–101
  25. Lo YM, Tein MS, Lau TK, et al. Quantitative analysis of fetal DNA in maternal plasma and serum: implications for noninvasive prenatal diagnosis. Am J Hum Genet. 1998;62:768–775
  26. Alberry M, Maddocks D, Jones M, et al. Free fetal DNA in maternal plasma in anembryonic pregnancies: confirmation that the origin is the trophoblast. Prenat Diagn. 2007;27:415–418
  27. Zhong XY, Holzgreve W, Hahn S. Cell-free fetal DNA maternal circulation does not stem from transplacental passage fetal erythroblast. Mol Hum Reprod. 2002;8:864–870
  28. Bobrow CS, Soothill PW. Fetal growth velocity: a cautionary tale. Lancet. 1999;353:1460
  29. Sekizawa A, Jimbo M, Saito H, et al. Cell-free fetal DNA in the plasma of pregnant women with severe fetal growth restriction. Am J Obstet Gynecol. 2003;188:480–484
  30. Tong YK, Ding C, Chiu RW, et al. Noninvasive prenatal detection of fetal trisomy 18 by epigenetic allelic ratio analysis in maternal plasma: theoretical and empirical considerations. Clin Chem. 2006;52:2194–2202

 This study was funded by the European SAFE Network of Excellence.

 Cite this article as: Alberry MS, Maddocks DG, Hadi MA, et al. Quantification of cell free fetal DNA in maternal plasma in normal pregnancies and pregnancies with placental dysfunction. Am J Obstet Gynecol 2009;200:98.e1-98.e6.

 Reprints not available from the authors.

PII: S0002-9378(08)00883-1

doi: 10.1016/j.ajog.2008.07.063

American Journal of Obstetrics & Gynecology
Volume 200, Issue 1 , Pages 98.e1-98.e6 , January 2009

Article Tools

* Image Usage & Resolution